We observed a significant increase in the expression of hif-1α on CD8+Tc amongst COVID(+) patients with metabolic syndrome, accompanied by a mild increase in glut-1 expression, suggesting that patients with prior metabolic comorbidities may have an increased hypoxia-driven anaerobic glycolysis (Supplementary Fig. 5a). Here, SLC2A1 is linked to metabolic syndrome.